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Abstract
Background: Acinar cell carcinoma represents only 1–2% of exocrine pancreatic neoplasms. On exceptionally rare
occasions, primary acinar cell carcinoma can occur in ectopic locations. Herein, we report a case of pure
pancreatic-type acinar cell carcinoma arising in the stomach.
Case presentation: A 54-year-old male presented with a gastric submucosal mass detected by endoscopic
examination. Laparoscopic wedge resection was performed. Macroscopically, the 2.7 cm yellowish mass was located
in the submucosa of the stomach. Microscopically, the tumor was well circumscribed and had a homogeneous
acinar architecture. The tumor cells were small and had a minimal amount of cytoplasm. The nuclei of the tumor
cells were round to oval with finely dispersed chromatin. The tumor cells were strongly positive for α1-antitrypsin,
chymotrypsin, and α1-antichymotrypsin immunostaining, consistent with pancreatic exocrine differentiation. There
was no clinical or radiologic evidence of primary pancreatic or head and neck tumors. After surgical resection of
the tumor, there was no recurrence or metastasis during 33 months follow-up.
Conclusion: In this report, we have presented a rare case of primary pure pancreatic-type acinar cell carcinoma
arising in the stomach and suggest that it could be helpful if the pathologist were aware that pancreatic-type
acinar cell carcinoma could arise in the stomach as a polypoid submucosal tumor in the routine diagnostic field of
gastric endoscopy.
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Background
Although, pancreatic neoplasms can occur in any of the
sites where heterotopic pancreatic tissue is present, the
incidence of extrapancreatic pancreatic-type neoplasms
is very rare; most are ductal adenocarcinomas and there
have been only a few cases of pancreatic-type acinar cell
carcinoma (ACC) [1–5]. ACC is also rare in the pan-
creas and represents approximately 1–2 and 15% of exo-
crine pancreatic neoplasms in adults and children,
respectively [6]. To date, there have been eight reported
cases of pure pancreatic-type ACCs located at extra-
pancreatic sites and five of which arose in the stomach
[1–5]. Herein, we present the sixth case of pure form of
primary pancreatic-type ACC arising in the stomach.
Informed consent was provided by the patient according
to the Declaration of Helsinki.
Case presentation
A 54-year-old male underwent an upper gastro-
intestinal endoscopic examination during a medical
check-up. Endoscopic examination revealed a gastric
submucosal mass near the cardia (Fig. 1a). An initial
endoscopic biopsy contained only non-neoplastic gastric
mucosa. Thereafter, the patient was transferred to our
hospital for the further evaluation. Abdominal computed
tomography showed a relatively well circumscribed mass
protruding into the lumen of the stomach near the car-
dia (Fig. 1b). As a submucosal tumor, a gastrointestinal
stromal tumor or a malignant lymphoma was suspected,
and laparoscopic wedge resection was performed as an
optimal diagnostic and therapeutic procedure. Macro-
scopically, the surface of the gastric mucosa was smooth
and intact. The cut surface showed 2.7 cm relatively well
* Correspondence: kyjang@chonbuk.ac.kr
†Equal contributors
1Department of Pathology, Chonbuk National University Medical School,
Research Institute of Clinical Medicine of Chonbuk National
University-Biomedical Research Institute of Chonbuk National University
Hospital and Research Institute for Endocrine Sciences, 567
Baekje-daeroDukjin-gu, Jeonju 561-756, Republic of Korea
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kim et al. Diagnostic Pathology  (2017) 12:10 
DOI 10.1186/s13000-017-0601-z
circumscribed yellowish submucosal mass with dilated
blood vessels (Fig. 1c). Microscopically, the tumor was
located within the submucosa and relatively
circumscribed, but a fibrous capsule was not present
(Fig. 2a). The tumor was cellular and had scanty stromal
components with no fibrous septum identified. The
tumor predominantly had an acinar and nested architec-
tural patterns (Fig. 2b and c). In acinar, the nuclei of the
tumor cells were basally located. The neoplastic cells
had a relatively small amount of clear or eosinophilic
Fig. 1 Endoscopic, radiologic, and gross features of the tumor. a Gastric submucosal mass protruded into the lumen and had an intact mucosa was
observed via endoscopic examination. b Abdominal computed tomography shows a relatively well circumscribed polypoid mass with homogenous
enhancement near the gastric cardia (arrow). c The cut surface of the tumor shows a relatively well circumscribed yellow-colored submucosal mass
Fig. 2 Histologic features of the tumor. Histologically, the tumor was located beneath the gastric mucosa (a) and showed an acinar (b) and solid
nested pattern in scanty fibrous stroma (c). Immunohistochemically, the tumor cells were strongly positive for α1-antitrypsin (d) and
α1-antichymotrypsin (e) and weakly positive for CD56 (f). The tumor cells were negative for neuroendocrine markers, such as chromogranin
A (g), synaptophysin (h), and thyroid transcription factor 1 (i). Original magnification: A; x100, B - I; x400
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cytoplasm, and the nuclei were uniform and round to
oval with finely dispersed chromatin and indistinct nu-
cleoli (Fig. 2b). Some tumor cells had a nuclei with a sin-
gle small nucleolus. The tumor cells in nests had very
scanty cytoplasm and the nuclei were overlapped
(Fig. 2c). However, there were no areas composed of
large sheets of tumor cells or having an infiltrative
growth pattern at the periphery of the tumor. Mitosis
was observed in fewer than one cell per 10 high-power
field. Neither atypical mitosis nor tumor necrosis was
seen. Immunohistochemistry showed strong, diffuse
positivity for α1-antitrypsin, chymotrypsin, α1-
antichymotrypsin, pan-cytokeratin, and vimentin and
weak diffuse positivity for CD56 and DOG1 (Fig. 2d, e,
and f). Synaptophysin, chromogranin A, TTF-1, c-Kit, S-
100 protein, and CD34 were negative (Fig. 2g, h, and i).
Ki67-positive cells were found at an incidence of fewer
than 10 in one high-power field. Based on the acinar
histologic features and the immunohistochemical stain-
ing, it was diagnosed as pancreatic-type of ACC of the
stomach. Thereafter, we carefully re-evaluated histologic
sections from the entire resected specimen and radio-
logic images. However, heterotopic pancreatic tissue was
not identified in the resected tissue specimens. There
was no specific abnormality in the pancreas or head and
neck in the radiographic studies, and the laboratory tests
were within normal limits. Because the resection margin
was clear and there were no additional lesions visualized
via position emission tomography-computed tomog-
raphy, the patient did not receive any adjuvant therapy
and is undergoing regular three-month follow-ups. At
the time of submission of this manuscript, the patient
has been alive and without evidence of recurrence or
metastasis for 33 months after resection.
Discussion
In this report, we present a rare case of primary pure
form pancreatic-type ACC of the stomach and summa-
rized previously reported cases in Table 1. There have
been only six reports, including the case presented in
this report [1–5]. Although there have been a limited
number of cases, the incidence is higher in males (the
male to female ratio is 2:1) and the age of the patients
has ranged from 52 to 86 years. The size of tumors
ranged from 2.7 cm in an asymptomatic case (present
case) to 7.6 cm in tumors directly invading the pancre-
atic head. Four of five cases presented as a mass
protruding into the gastric lumen.
Because of rarity of extra-pancreatic ACC, the diagno-
sis of ACC could be challenging. In such cases, immuno-
histochemical detection of acinar differentiation, with
markers such as trypsin, chymotrypsin, lipase, and amyl-
ase is helpful in the diagnosis of ACC [1–8]. However, if
there are substantial amounts of endocrine or ductal
components (more than 25% of the tumors) mixed car-
cinomas should be distinguished [6] and trypsin-
positivity also seen in gastric neuroendocrine tumors [9].
Therefore, evaluation of neuroendocrine markers is
needed to diagnose the pure form of ACC. Strong
immunoreactivity for pancreatic exocrine enzymes along
with negativity for neuroendocrine markers indicates
ACC [1–5]. However, weak or focal expression of neuro-
endocrine markers, such as chromogranin, synaptophy-
sin, and CD56 have also been observed (cases 4, and 5
in Table 1) [1, 5]. In our case, although the intensity of
the expression was weak, the tumor cells were positive
for CD56. Therefore, in addition to a neuroendocrine
tumor, a mixed acinar-neuroendocrine carcinoma should
also be considered during diagnosis. However, the tumor
cells were completely negative for other common neuro-
endocrine markers such as chromogranin A,
synaptophysin, and TTF-1. Moreover, acinar differenti-
ation of the tumor cells was indicated by strong immu-
noreactivity for α1-antitrypsin, chymotrypsin, and
α1-antichymotrypsin and there were no definitive endo-
crine components as a part of mixed carcinoma. In
addition, the expression of CD56 could be seen in vari-
ous types of non-neuroendocrine tumors [10]. There-
fore, we could make a diagnosis of pure ACC. In
addition, one interesting finding during the diagnostic
approach for the gastric pancreatic-type ACC is that the
initial diagnosis of the endoscopic biopsy was poorly
differentiated adenocarcinoma in four cases (cases 1, 3,
4, and 5) [1, 2, 4, 5]. In two cases (cases 2 and 6), initial
biopsies were inconclusive and radiologic findings sug-
gested gastrointestinal stromal tumor or malignant
lymphoma [3]. These findings suggest that if there are
tumor cells with acinar differentiation in gastric mucosal
biopsies, immunohistochemical staining for pancreatic
exocrine differentiation might be helpful for diagnosis,
especially for tumors presenting as polypoid and/or
submucosal tumors.
Concerning the origin of pancreatic-type ACC in the
stomach, it has been suggested that it originates from
pancreatic metaplasia or heterotopic pancreatic tissue.
Among the five previously reported cases of gastric
ACCs, one case had metaplastic pancreatic tissue in the
adjacent gastric mucosa [1]. However, metaplastic pan-
creatic tissue is not mentioned nor identified in the
other cases of primary pure ACC of the stomach (cases
1, 2, 4, 5, and 6 in Table 1) [2–5]. Therefore, the possi-
bility that gastric ACC derived from the gastric hetero-
topic pancreas was suggested. As we have summarized
in Table 1, the six cases of primary pure ACC of the
stomach, including our case, were suspected to have
originated from heterotopic pancreatic tissue. This
assumption was based on the fact that heterotopic pan-
creas is usually located in the submucosa [11] and that


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Kim et al. Diagnostic Pathology  (2017) 12:10 Page 4 of 6
in three cases (cases 1, 2, and 6) it was also located
mainly at the submucosa and pancreatic metaplasia was
not identified in most cases [2–5]. However, the possibil-
ity that ACC is derived from heterotopic pancreatic tis-
sue is also questionable. In five cases of pure pancreatic-
type ACC in the stomach (cases 1, 2, 4, 5, and 6), ectopic
pancreatic tissue was not identified and there was no
evidence of tumors in locations other than the stomach,
such as in the pancreas or the head and neck area in
four cases [2–5]. Therefore, although it is not difficult to
define the origin of ACC of the stomach, this type of
tumor might be regarded as a primary gastric tumor and
separately considered from the pancreatic ACC. In
addition, further investigation of additional cases is
needed to define the exact nature of pancreatic-type
ACC in the stomach.
Although pancreatic ACC is not as lethal as pancreatic
ductal adenocarcinoma, it has also been reported as one
of the most aggressive malignant tumors [8]. The me-
dian survival of pancreas ACC patients with localized
disease and metastatic disease is 38 and 14 months, re-
spectively [8]. However, the prognosis of primary ACC
of the stomach is not clear because of the limited num-
ber of cases, and the outcomes are not clear even in the
cases that have been reported. As we summarized in
Table 1, although there was no cancer-specific outcomes
of the patients, partial gastrectomies were performed in
two cases and subtotal gastrectomies were performed in
one case as therapeutic operations [1, 2, 4]. One patient
that underwent partial gastrectomy died 1 month after
the operation from complications [2]. Recently, there
was a report of an autopsy case of gastric ACC accom-
panied advanced pancreatic ductal adenocarcinoma me-
tastasized to lymph node, liver, and peritoneum [5].
Therefore, it was difficult to assume the biologic behav-
ior of gastric ACC. Another report showed that even a
patient with a tumor that had invaded the pancreas and
metastasized to lymph nodes was alive 11 months after
an operation, despite metastatic relapse in the liver at
7 months after operation [3]. In our case, the patient has
been disease-free for 33 months after a limited surgical
procedure, laparoscopic wedge resection. The relatively
limited progression of our case might be due to early
detection of the tumor by endoscopy during a medical
check-up. These findings suggest that prognosis might
be related with stage of tumor as it is with primary
pancreatic ACC [6].
Conclusion
In conclusion, we have presented a rare case of primary
pure pancreatic-type ACC arising in the stomach.
Although it is difficult to consider gastric ACC in the
routine diagnostic field of gastric mucosal biopsy due to
its rarity, it could be helpful if the pathologist were
aware that pancreatic-type ACCs could arise in the
stomach as a polypoid submucosal tumor. In addition, if
a tumor has the acinar architectural pattern, a check for
the pancreatic exocrine differentiation might be helpful
in diagnosis.
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